back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-05-06 12:36 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2019-05-06 12:35 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,500,000 | ||
| Filed 2019-05-06 12:34 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-05-06 12:34 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+100,000 vol $1.00 each |
||
| Filed 2019-05-06 12:34 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-05-06 12:33 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+1,500,000 vol $0.01 each |
||
| Filed 2019-05-06 12:32 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-05-06 12:32 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-04-28 11:26 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+100,000 vol $1.00 each |
||
| Filed 2019-04-28 11:19 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+1,500,000 vol $0.01 each |
||
| Filed 2019-03-15 16:05 Tx date 2018-06-06 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-03-15 16:03 Tx date 2018-06-06 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-04-28 11:26 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+100,000 vol $1.00 each |
100,000 | |
| Filed 2019-04-28 11:23 Tx date 2019-01-17 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+100,000 vol $1.00 each |
||
| Filed 2019-04-28 11:21 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
97 - Other
|
$100,000
+100,000 vol $1.00 each |
||
| Filed 2019-04-28 11:19 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+1,500,000 vol $0.01 each |
1,500,000 | |
| Filed 2019-04-28 11:18 Tx date 2018-06-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+1,500,000 vol $0.01 each |
||
| Filed 2019-04-28 11:18 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+1,500,000 vol $0.01 each |
||
| Filed 2019-04-28 11:16 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+1,500,000 vol $0.01 each |
||
| Filed 2019-04-28 11:10 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
97 - Other
|
$100,000
+100,000 vol $1.00 each |
||
| Filed 2019-04-28 11:02 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$15,000
+1,500,000 vol $0.01 each |
||
| Filed 2019-03-15 16:07 Tx date 2019-01-17 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+100,000 vol $1.00 each |
||
| Filed 2019-03-15 16:04 Tx date 2018-06-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+1,500,000 vol $0.01 each |
||
| Filed 2019-03-15 Tx date 2018-06-19 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+1,500,000 vol $0.01 each |
1,500,000 | |
| Filed 2019-03-15 Tx date 2019-01-17 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+100,000 vol $1.00 each |
100,000 | |
| Filed 2019-03-15 Tx date 2018-06-06 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-03-15 Tx date 2018-06-06 |
$NGEN
NervGen Pharma Corp. |
Wong, Ernest Shing-Yan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|